KAI-1678

DRUG3 trials

Sponsors

KAI Pharmaceuticals

Conditions

Pain, PostoperativePostherpetic NeuralgiaSpinal Cord Injury

Phase 2

Safety and Efficacy Study of KAI-1678 to Treat Subjects With Postoperative Pain

CompletedNCT01015235

KAI PharmaceuticalsPain, Postoperative

Start: 2008-12-31End: 2010-02-28Updated: 2011-09-02

Safety and Efficacy Study of KAI-1678 to Treat Pain in Subjects With Postherpetic Neuralgia

CompletedNCT01106716

KAI PharmaceuticalsPostherpetic Neuralgia

Start: 2009-03-31End: 2010-04-30Updated: 2025-09-02

Safety and Efficacy Study of KAI-1678 to Treat Pain in Subjects With Spinal Cord Injury

CompletedNCT01135108

KAI PharmaceuticalsSpinal Cord Injury

Start: 2009-03-31End: 2010-05-31Updated: 2025-09-02